Sign Our Open Letter to AstraZeneca June 7, 2024
Urgent Appeal for the Introduction of Symbicort Turbuhaler DPI to the U.S.
We, as health and sustainability professionals and organizations concerned about the impact of the accelerating climate crisis on public health, are writing to AstraZeneca with a plea to make their Symbicort Turbuhaler dry powder inhaler (DPI) available in the United States as soon as possible.
You can read the full letter here.
Deadline to sign: July 1
More Action Alert
Opinion: Physicians Must Reduce Plastic Waste
By Bridget Lee, MD, GBPSR Board Member in ACEP Now Health care has grown dependent on plastic. Plastic is involved in virtually every patient interaction,...
Dr. Brita Lundberg on Gas Leaf Blowers
The Massachusetts Medical Society has acknowledged the risks of gas leaf blowers. Brita Lundberg, MD, Board member of Greater Boston Physicians for Social Responsibility, spells...
An urgent call to bring an affordable, climate-friendly inhaler to the US
Dr. Wynne Armand, GBPSR board member | Health Care Without Harm Asthma is a disease with known disparities including more severe disease in both people...